Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2026 07:00 ET | Source: Fate Therapeutics, Inc.

Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies

Commercial leader brings lupus nephritis and first-in-class launch experience as FT819 advances in the RECLAIM-LN Phase 2 trial Proven record in advancing breakthrough autoimmune therapies and...
October 12, 2026 07:00 ET | Source: OTC Markets

World's Largest Stock Transfer Agent Computershare Begins Trading on OTCQX Best Market

NEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Computershare...
October 12, 2026 07:00 ET | Source: Greenland Mines Ltd

Greenland Mines Welcomes EU Selection of Neo Performance Materials’ Silmet 2.0 as Strategic Project; Highlights Sarfartoq’s Potential Role in Secure Transatlantic Rare Earth Supply

CHARLOTTE, N.C., Oct. 12, 2026 (GLOBE NEWSWIRE) -- via IBN – Greenland Mines Ltd (Nasdaq: GRML; FSE: HK6) ("Greenland Mines" or the "Company"), a Western-aligned critical-minerals developer...
October 12, 2026 07:00 ET | Source: IRIDEX Corporation

Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma

SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the...
October 12, 2026 07:00 ET | Source: Beacon Therapeutics (USA), Inc.

Beacon Therapeutics Presents Data from Pivotal VISTA Trial of Laru-zova at AAO 2026

Late-breaking oral presentation at Retina Subspecialty Day outlines data from Beacon’s pivotal VISTA trial, which met its FDA-endorsed primary endpoint with statistical significance31.0% of...
October 12, 2026 07:00 ET | Source: Harmony Biosciences

Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth

The Board of Directors has appointed Peter Anastasiou, former Harmony board member and current Sr. EVP and COO, to become President, Chief Executive Officer and a member of the Board, effective...
October 12, 2026 07:00 ET | Source: Gray Media

St. Louis Blues Unveil Thursday Night Blues Package Of 10 Over-The-Air Games Simulcasting On St. Louis’ First Alert ABC and 10 Other Gray Media Markets During the 2026-27 Season

ATLANTA, Oct. 12, 2026 (GLOBE NEWSWIRE) -- The St. Louis Blues and Gray Media today announced a multi-year partnership to simulcast 10 select Blue Note+ telecasts over-the-air on First...
October 12, 2026 07:00 ET | Source: Zenas BioPharma

Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease

– Phase 3 INDIGO open-label extension findings demonstrated sustained clinical activity of obexelimab – – Additional analyses of secondary endpoints showed that significantly fewer patients...
October 12, 2026 07:00 ET | Source: Polar Power, Inc.

POLAR POWER ANNOUNCES MANAGEMENT RESTRUCTURING WITH NEW CEO ALIGNMENT

GARDENA, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Polar Power, Inc. (NASDAQ: POLA) (the “Company” or “Polar Power”), a global provider of prime, backup and solar hybrid power solutions, today...
October 12, 2026 07:00 ET | Source: Vivani Medical, Inc.

Vivani Medical Announces Participation in Upcoming Investor Conferences

ALAMEDA, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra-long-acting...